CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 4 Open-market buy 10% owner bought 6,536 shares
- SC 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 3,268 shares (grant or award)
- 4 Grant or award Director acquired 4,902 shares (grant or award)
- 4 Grant or award Director acquired 3,268 shares (grant or award)
- 4 Grant or award Director acquired 3,268 shares (grant or award)
- 4 Grant or award CEO acquired 13,072 shares (grant or award)
- 8-K Event Delisting notice
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Executive or director change
Page 10 of 78 · 1,549 filings